Yijing Capital is an investment company based in Shanghai, China. Founded in 2015, the company primarily focuses on investments in the medical and health-care sector. Operating in the Asia-Pacific (APAC) region, Yijing Capital has established itself as a prominent player in the biotech, pharma, and Biomed industries. One of their notable investments includes Artivila Therapeutics, showcasing their...